Microbial Cells Analysis Instrument Sales

Microbial Cells Analysis Instrument Sales Market Outlook

The global microbial cells analysis instrument market was valued at approximately USD 4.5 billion in 2023 and is projected to reach USD 8.1 billion by 2035, growing at a CAGR of around 7.4% during the forecast period. The increasing prevalence of infectious diseases and the growing demand for rapid diagnostic tools are significant drivers of this market's expansion. Moreover, advancements in biotechnology and a surge in research activities related to microbial genomics are expected to foster substantial growth. The rising emphasis on food safety and quality assurance also contributes significantly to market demands. These factors combine to create a robust growth environment for microbial cells analysis instruments across various sectors, including healthcare, food, and pharmaceuticals.

Growth Factor of the Market

The growth of the microbial cells analysis instrument market is primarily attributed to rising public health concerns regarding infectious diseases, which necessitate effective diagnostic tools. Additionally, the ongoing research and development initiatives aimed at understanding microbial behaviors and interactions are propelling market growth. The increasing investment in biotechnology and life sciences sectors is further enhancing the demand for advanced microbial analysis tools. Regulatory bodies are emphasizing stringent food safety regulations, thereby promoting the adoption of microbial analysis instruments in food testing laboratories. Furthermore, the rise in the global population coupled with the growing awareness of hygiene standards is driving the need for microbial testing in various applications, solidifying the market’s growth trajectory.

Key Highlights of the Market

• Projected market growth with a CAGR of 7.4% from 2023 to 2035.
• Increased investment in biotechnology and life sciences driving demand.
• Need for rapid diagnostic tools due to rising infectious diseases.
• Growing emphasis on food safety and quality assurance.
• Expansion of research activities related to microbial genomics.

By Product Type

Flow Cytometry Instruments:

Flow cytometry instruments play a pivotal role in the microbial cells analysis market due to their ability to quickly analyze physical and chemical characteristics of cells in a fluid stream. These instruments are utilized extensively in clinical diagnostics and research applications, allowing for the precise assessment of microbial populations and their interactions. The growing interest in personalized medicine and targeted therapies is further boosting the demand for flow cytometry. The technology's high throughput capabilities and ability to provide multiparameter analysis make it essential for diverse applications, including immunology and cell biology research, thus positioning it as a significant contributor to market growth.

Microplate Readers:

Microplate readers are crucial in the microbial cells analysis landscape, offering enhanced capacity for high-throughput screening applications. These instruments are commonly employed in research laboratories for analyzing enzyme-linked immunosorbent assays (ELISAs) and other biochemical assays. The increasing adoption of microplate technology in laboratories due to its ability to conduct simultaneous analyses of multiple samples is driving market demand. Furthermore, advancements in microplate technology, such as the integration of automation and real-time monitoring capabilities, contribute to their rising popularity in both clinical and research settings, making them a vital segment in the microbial analysis market.

PCR Instruments:

Polymerase Chain Reaction (PCR) instruments are indispensable in microbial analysis for their ability to amplify specific DNA sequences, facilitating the identification of microbial pathogens. Their applications extend across clinical diagnostics, research, and food safety testing, where rapid identification is critical. The growth of molecular diagnostics and the increasing prevalence of genetic testing are key factors driving the adoption of PCR technology. Moreover, innovations in PCR methods, such as real-time PCR and digital PCR, provide enhanced sensitivity and specificity, further solidifying their importance in the microbial cells analysis market.

Microscopes:

Microscopes, particularly advanced imaging systems, are essential tools for observing microbial morphology and behavior in various research and clinical applications. The surge in microbiological research aimed at understanding microbial interactions and resistance mechanisms is fostering growth in this segment. Innovations in microscopy techniques, such as fluorescence microscopy and electron microscopy, enable researchers to visualize microbes at the cellular and molecular levels, which is crucial for studying pathogenic organisms. The increasing demand for quality control and assurance in pharmaceuticals and food industries also reinforces the growing reliance on microscopy for microbial analysis.

Spectrophotometers:

Spectrophotometers are widely used in microbial cells analysis for quantifying microbial growth and analyzing cell constituents. They enable researchers and quality control laboratories to assess the concentration of microbial cells in various samples. The versatility and ease of use of spectrophotometers contribute to their widespread adoption across multiple sectors, including healthcare, environmental monitoring, and food testing. The rising need for rapid and accurate microbial analysis techniques further drives demand within this segment, as spectrophotometers provide a fast and efficient means to evaluate microbial populations and their characteristics.

By Application

Clinical Diagnosis:

In clinical diagnosis, microbial cells analysis instruments are pivotal for identifying and quantifying pathogens responsible for infectious diseases. The increasing incidence of chronic and infectious diseases necessitates rapid diagnostic tools to facilitate timely treatment decisions. These instruments aid healthcare professionals in diagnosing diseases accurately and efficiently, significantly contributing to improved patient outcomes. The emphasis on personalized medicine and tailored treatment strategies further underscores the importance of microbial analysis in clinical settings, making this application a key driver of market growth.

Research:

The research application of microbial analysis instruments is critical for advancing our understanding of microbial ecology, pathogenicity, and resistance mechanisms. Researchers utilize these instruments to study microbial behavior, interactions, and evolutionary dynamics, which are essential for developing effective treatments and interventions. The increased funding and investment in microbiome research and biotechnology are propelling market growth within this segment. Moreover, collaborations between academic institutions and industry players are enhancing research capabilities, further driving the demand for microbial analysis tools in scientific studies.

Food and Beverage Testing:

Food and beverage testing is an essential application of microbial cells analysis instruments, ensuring the safety and quality of consumables. Regulatory bodies enforce stringent food safety standards that require effective testing methods to detect contaminants and pathogens in food products. The increasing consumer awareness regarding food safety and quality is driving the adoption of microbial analysis tools in food testing laboratories. Moreover, the growing trend of organic and natural food products necessitates rigorous testing for microbial contaminants, further reinforcing the importance of microbial analysis instruments in this sector.

Environmental Monitoring:

Environmental monitoring applications utilize microbial analysis instruments to assess water quality, air quality, and soil health, providing crucial data for environmental protection. The rising concerns about pollution and its impact on public health and ecosystems are driving the demand for effective monitoring solutions. Instruments that facilitate rapid microbial analysis are essential for regulatory compliance and environmental assessments. The increasing emphasis on sustainability and ecological conservation further underscores the importance of microbial analysis tools in monitoring environmental parameters, driving growth in this segment.

Pharmaceuticals:

In the pharmaceutical sector, microbial cells analysis instruments are critical for quality control and assurance processes. These instruments are employed to detect and quantify microbial contaminants in drug products, ensuring compliance with regulatory standards. The rising focus on biopharmaceuticals and the increasing complexity of drug formulations necessitate advanced microbial analysis tools. Additionally, the growing trend of personalized medicine and biologics development emphasizes the need for rigorous microbial testing, thereby driving market growth in the pharmaceutical application segment.

By User

Hospitals and Clinics:

Hospitals and clinics represent a significant user segment for microbial cells analysis instruments due to their critical role in clinical diagnostics. These healthcare facilities require rapid and accurate microbial testing to diagnose infections and determine appropriate treatment options. The increasing patient population and the rising prevalence of infectious diseases drive the demand for advanced diagnostic tools in these settings. Moreover, the integration of automated systems in hospitals enhances laboratory efficiency and accuracy, further solidifying the importance of microbial analysis instruments in clinical environments.

Research Laboratories:

Research laboratories are key users of microbial cells analysis instruments, utilizing them for diverse applications ranging from fundamental microbiological research to applied sciences. The growing emphasis on microbial genomics and biotechnology research is propelling the demand for advanced analytical tools in these settings. Research institutions are increasingly engaged in collaborative projects that require high-throughput screening and precise microbial analysis capabilities. The continuous advancements in research methodologies and technologies also drive the innovation and adoption of microbial analysis instruments in laboratories worldwide.

Food Testing Laboratories:

Food testing laboratories are essential users of microbial cells analysis instruments, as they are responsible for ensuring the safety and compliance of food products. The rising consumer awareness regarding food safety and quality is driving the demand for effective microbial testing methods in these laboratories. Stringent regulatory standards necessitate the use of accurate and reliable instruments to detect microbial contaminants in food products. Consequently, food testing laboratories must adopt advanced microbial analysis tools to meet consumer expectations and regulatory requirements, further boosting their significance in the market.

Environmental Monitoring Agencies:

Environmental monitoring agencies rely on microbial cells analysis instruments to assess and monitor environmental health and safety. These agencies use advanced microbial analysis tools to evaluate water, air, and soil samples for contamination by pathogenic organisms and pollutants. The increasing focus on environmental sustainability and public health drives the demand for effective monitoring solutions. Additionally, regulatory frameworks require these agencies to adopt rigorous testing methodologies, further emphasizing the importance of microbial analysis instruments in ensuring environmental safety and compliance.

Pharmaceutical Companies:

Pharmaceutical companies are significant users of microbial cells analysis instruments, as they are essential for quality control processes in drug manufacturing. These companies utilize microbial analysis tools to ensure compliance with stringent regulatory standards and to detect contaminants in drug products. The increasing complexity of drug formulations, particularly in biopharmaceuticals, necessitates advanced microbial testing capabilities. As pharmaceutical companies continually strive to enhance product quality and efficacy, their reliance on microbial analysis instruments will only increase, highlighting the critical nature of these tools in the industry.

By Analysis Type

Quantitative Analysis:

Quantitative analysis is a crucial aspect of microbial cells analysis, allowing researchers and clinicians to determine the concentration of microbial populations in various samples. This type of analysis is essential for understanding microbial loads in clinical diagnostics, environmental monitoring, and food safety testing. The ability to accurately quantify microbial counts is vital for assessing contamination levels and ensuring compliance with health and safety regulations. The increasing demand for rapid and reliable quantitative methods is driving innovations in microbial analysis instruments, further solidifying this segment's importance in the market.

Qualitative Analysis:

Qualitative analysis in microbial cells analysis focuses on identifying the presence of specific microorganisms within a sample. This type of analysis is fundamental in clinical diagnostics, environmental assessments, and food testing, where understanding microbial diversity is crucial. The adoption of advanced technologies in qualitative analysis, such as molecular techniques and culture-independent methods, enhances the accuracy and efficiency of microbial identification processes. As researchers and industry professionals seek comprehensive microbial profiles, the demand for qualitative analysis tools continues to grow, propelling market expansion.

Microbial Identification:

Microbial identification is a critical application of microbial cells analysis instruments, enabling the detection and characterization of specific pathogens. This analysis type is vital in clinical laboratories for diagnosing infections, as well as in food and environmental sectors for ensuring safety standards. The rise in molecular diagnostic techniques, such as PCR and next-generation sequencing, enhances the capabilities of microbial identification tools. Additionally, the increasing focus on understanding microbial communities and their roles in health and disease drives demand for advanced identification methods, further boosting this market segment.

Antimicrobial Susceptibility Testing:

Antimicrobial susceptibility testing (AST) is essential for determining the effectiveness of antibiotics against specific microbial strains. This analysis type plays a critical role in clinical settings, enabling healthcare providers to make informed decisions regarding treatment options. The growing prevalence of antibiotic-resistant infections necessitates the adoption of reliable AST methods to guide effective therapy choices. The demand for innovative AST technologies, such as automated systems and rapid testing methods, is increasing as researchers and clinicians seek to address the challenges posed by resistant organisms, thereby driving growth in this market segment.

Microbial Count:

Microbial count analysis is fundamental for assessing the total viable microbial load in a sample, which is crucial for various applications including clinical diagnostics, food safety, and environmental monitoring. Accurate microbial counting enables laboratories to evaluate contamination levels and ensure compliance with regulatory standards. The increasing demand for rapid and efficient counting methods is driving advancements in microbial analysis technologies. Moreover, the rise in consumer awareness regarding hygiene and safety standards in food and pharmaceuticals emphasizes the need for precise microbial counting, further boosting this segment of the market.

By Region

The North American region dominates the microbial cells analysis instrument market, accounting for approximately 38% of the global market share in 2023. The robust healthcare infrastructure, coupled with significant investments in biotechnology and pharmaceutical research, drives market growth in this region. Additionally, the increasing prevalence of infectious diseases and the growing emphasis on food safety regulations further contribute to the heightened demand for microbial analysis tools. The North American market is expected to witness a CAGR of around 7.8% during the forecast period, making it a critical area for industry players.

In Europe, the microbial cells analysis instrument market is also experiencing substantial growth, with a share of about 30% in 2023. The region benefits from a strong focus on research and development, supported by governmental initiatives and funding aimed at enhancing public health and safety. The growing awareness regarding environmental sustainability and stringent regulations surrounding food safety are key factors propelling the market in Europe. Additionally, the increasing collaboration between academic institutions and industry stakeholders is fostering innovation, further enhancing the growth prospects for the microbial analysis market in the region.

Opportunities

The microbial cells analysis instrument market presents numerous opportunities for growth and innovation, particularly in the expanding fields of molecular diagnostics and biotechnology. As healthcare systems worldwide shift towards personalized medicine, the demand for accurate and rapid microbial testing methods is rising. This trend offers significant opportunities for companies to develop advanced instruments that cater to the evolving needs of clinical diagnostics, research, and quality control. Furthermore, ongoing advancements in technology, such as automation and artificial intelligence, provide avenues for enhancing efficiency and accuracy in microbial analysis, creating a conducive environment for market players to innovate and expand their product offerings.

Moreover, the growing global focus on food safety and environmental sustainability presents additional opportunities for market growth. As consumers become more conscious of food quality and safety standards, the demand for effective microbial testing in food production and processing is increasing. Similarly, the need for robust environmental monitoring solutions to assess air, water, and soil quality is driving the market for microbial analysis instruments in this sector. Companies that can leverage these trends to offer specialized solutions tailored to food and environmental applications stand to gain a competitive edge and capture a larger market share.

Threats

Despite the significant growth potential in the microbial cells analysis instrument market, several threats could hinder market advancement. One of the primary threats is the increasing competition among market players, which may lead to price wars and reduced profit margins. Additionally, the rapid pace of technological advancements may result in obsolescence for existing instruments, compelling companies to continuously innovate to stay relevant. Furthermore, regulatory compliance and quality standards pose challenges for manufacturers, as failure to meet these requirements can lead to financial losses and reputational damage. Companies must navigate these challenges effectively to maintain their market position and ensure sustainable growth.

A critical restraining factor for the microbial cells analysis instrument market includes the high cost associated with advanced analytical instruments, which may limit accessibility for smaller laboratories and research facilities. Many organizations in developing regions struggle to invest in state-of-the-art technologies, leading to a potential market imbalance. Additionally, the complexity of microbial analysis techniques may necessitate specialized training and expertise, further constraining the market. Addressing these challenges through cost-effective solutions and training initiatives could enhance market penetration and promote wider adoption of microbial analysis instruments across various sectors.

Competitor Outlook

• Thermo Fisher Scientific
• BD (Becton, Dickinson and Company)
• Beckman Coulter, Inc.
• Merck KGaA
• Agilent Technologies
• Bio-Rad Laboratories, Inc.
• PerkinElmer, Inc.
• Eppendorf AG
• MilliporeSigma
• Hach Company
• Idexx Laboratories, Inc.
• LabCorp
• Qiagen N.V.
• Roche Diagnostics
• Charles River Laboratories

The competitive landscape of the microbial cells analysis instrument market is characterized by the presence of several key players that continuously innovate and expand their product offerings. These companies possess strong research and development capabilities, allowing them to introduce advanced instruments that cater to the diverse needs of clinical, research, and food safety applications. The market is witnessing intensified competition, with players focusing on strategic partnerships, mergers, and acquisitions to enhance their market position and expand their geographic reach. Furthermore, companies are investing in developing user-friendly and automated solutions to cater to the growing demand for efficiency in microbial analysis.

Thermo Fisher Scientific is a leading player in the microbial cells analysis instrument market, offering a wide range of products such as flow cytometers, PCR instruments, and spectrophotometers. The company’s commitment to innovation and quality has positioned it as a trusted supplier among researchers and clinicians. Additionally, Thermo Fisher’s strong global presence and extensive distribution network enable it to serve diverse markets effectively. BD (Becton, Dickinson and Company) is another significant player, known for its advanced diagnostic solutions and commitment to improving patient outcomes through innovative microbial analysis technologies. With a focus on clinical diagnostics and research applications, BD continues to invest in new technologies to enhance its product portfolio.

Bio-Rad Laboratories, Inc. is renowned for its cutting-edge products in the life sciences field, including instruments for microbial analysis. The company emphasizes innovation and quality in its offerings, making it a preferred choice among researchers and laboratories. Furthermore, Agilent Technologies and Merck KGaA are notable players in the market, providing advanced solutions that cater to various applications, including pharmaceuticals and environmental monitoring. Their continuous investment in research and development underscores their commitment to meeting the evolving needs of the microbial cells analysis market, ensuring they remain competitive in this dynamic landscape.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 LabCorp
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Merck KGaA
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Qiagen N.V.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Eppendorf AG
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Hach Company
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 MilliporeSigma
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 PerkinElmer, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Roche Diagnostics
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Agilent Technologies
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Beckman Coulter, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Idexx Laboratories, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Thermo Fisher Scientific
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Bio-Rad Laboratories, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Charles River Laboratories
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 BD (Becton, Dickinson and Company)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Microbial Cells Analysis Instrument Sales Market, By User
    • 6.1.1 Hospitals and Clinics
    • 6.1.2 Research Laboratories
    • 6.1.3 Food Testing Laboratories
    • 6.1.4 Environmental Monitoring Agencies
    • 6.1.5 Pharmaceutical Companies
  • 6.2 Microbial Cells Analysis Instrument Sales Market, By Application
    • 6.2.1 Clinical Diagnosis
    • 6.2.2 Research
    • 6.2.3 Food and Beverage Testing
    • 6.2.4 Environmental Monitoring
    • 6.2.5 Pharmaceuticals
  • 6.3 Microbial Cells Analysis Instrument Sales Market, By Product Type
    • 6.3.1 Flow Cytometry Instruments
    • 6.3.2 Microplate Readers
    • 6.3.3 PCR Instruments
    • 6.3.4 Microscopes
    • 6.3.5 Spectrophotometers
  • 6.4 Microbial Cells Analysis Instrument Sales Market, By Analysis Type
    • 6.4.1 Quantitative Analysis
    • 6.4.2 Qualitative Analysis
    • 6.4.3 Microbial Identification
    • 6.4.4 Antimicrobial Susceptibility Testing
    • 6.4.5 Microbial Count

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Microbial Cells Analysis Instrument Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Microbial Cells Analysis Instrument Sales market is categorized based on

By Product Type

• Flow Cytometry Instruments
• Microplate Readers
• PCR Instruments
• Microscopes
• Spectrophotometers

By Application

• Clinical Diagnosis
• Research
• Food and Beverage Testing
• Environmental Monitoring
• Pharmaceuticals

By User

• Hospitals and Clinics
• Research Laboratories
• Food Testing Laboratories
• Environmental Monitoring Agencies
• Pharmaceutical Companies

By Analysis Type

• Quantitative Analysis
• Qualitative Analysis
• Microbial Identification
• Antimicrobial Susceptibility Testing
• Microbial Count

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific
• BD (Becton, Dickinson and Company)
• Beckman Coulter, Inc.
• Merck KGaA
• Agilent Technologies
• Bio-Rad Laboratories, Inc.
• PerkinElmer, Inc.
• Eppendorf AG
• MilliporeSigma
• Hach Company
• Idexx Laboratories, Inc.
• LabCorp
• Qiagen N.V.
• Roche Diagnostics
• Charles River Laboratories